Rachel W Linnemann MD
Attending Physician, Children’s Healthcare of Atlanta Associate Professor, Emory University School of Medicine
Join to View Full Profile
1400 Tullie Rd NEFl 5Atlanta, GA 30329
Phone+1 404-785-5437
Fax+1 404-785-9087
Dr. Linnemann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Pediatric Pulmonology, 2012 - 2015- Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 2009 - 2012
Yale School of MedicineClass of 2009
Certifications & Licensure
GA State Medical License 2015 - 2026
MA State Medical License 2011 - 2016
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- Pragmatic Implementation Trial of a CF Primary Palliative Care Intervention Start of enrollment: 2021 Jun 25
Roles: Contact, Principal Investigator
- Trikafta in Cystic Fibrosis Patients Start of enrollment: 2019 Sep 04
Roles: Contact
Publications & Presentations
PubMed
- 3 citationsVanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 a...Claire Keating, Lael M Yonker, François Vermeulen, Dario Prais, Rachel W Linnemann
The Lancet. Respiratory Medicine. 2025-03-01 - 2 citationsEvaluation of elexacaftor-tezacaftor-ivacaftor treatment in individuals with cystic fibrosis and CFTRin the USA: a prospective, multicentre, open-label, single-arm trial.George M Solomon, Rachel W Linnemann, Rachel Rich, Ashleigh Streby, Brian Buehler
The Lancet. Respiratory Medicine. 2024-12-01 - 3 citationsImpact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.Nicole Mayer-Hamblett, Alex H Gifford, Margaret Kloster, Renee Russell, Andrew T Braun
Annals of the American Thoracic Society. 2024-11-01
Press Mentions
Children’s Healthcare of Atlanta and Emory University Cystic Fibrosis Care Center Receives Cystic Fibrosis Foundation’s 2024 Outstanding Care Center Partnership AwardNovember 26th, 2024- Transition Planning for Chronic Illnesses in the Time of COVID-19December 3rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
